BGB-11417

· BeiGene

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for BGB-11417, covering 2025-04-17 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study of BGB-11417 in Participants With Myeloid Malignancies [Phase 1, Phase 2]